CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
CRYO CELL INTERNATIONAL INC
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026
$4.65+0.23 (+5.20%)
Close on Oct 19, 2026
- Market cap
- $37.50M
- P/E (TTM)
- –
- Dividend yield
- –
CRYO CELL INTERNATIONAL INC revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member] | $31.00M | $31.16M | $31.38M | $31.39M | $31.52M | $31.61M | $31.55M | $31.51M | $31.42M | $31.04M | $30.80M | $30.62M | 99.6% | -1.6% |
| PrepaCyte CB [Member] | $71.53K | $71.79K | $54.10K | $64.20K | $64.40K | $85.80K | $67.88K | $44.01K | $45.91K | $37.26K | $66.46K | $90.32K | 0.2% | +11.1% |
| Public Cord Blood Banking [Member] | $52.64K | $48.84K | $129.51K | $289.76K | $406.25K | $405.04K | $366.67K | $288.05K | $171.83K | $294.16K | $481.15K | $523.12K | 0.2% | -87.0% |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member] | $4.62M | $5.01M | $5.41M | $4.94M | $4.45M | $4.32M | $4.13M | -$8.13M | -$8.33M | -$8.66M | -$7.91M | $4.98M | +3.8% |
| PrepaCyte CB [Member] | $38.30K | $33.36K | $14.21K | $19.35K | $16.16K | $31.46K | -$4.98K | -$28.91K | -$26.77K | -$34.37K | $3.19K | -$1.67K | +137.0% |
| Public Cord Blood Banking [Member] | -$4.76M | -$4.85M | -$4.94M | -$631.47K | -$648.35K | -$633.38K | -$646.54K | -$4.41M | -$4.44M | -$4.47M | -$4.40M | -$701.64K | +634.3% |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Processing and Storage Fees [Member] | $31.00M | $31.16M | $31.38M | $31.39M | $31.52M | $31.61M | $31.55M | $31.51M | $31.42M | $31.04M | $30.80M | $30.62M | 99.6% | -1.6% |
| Product Revenue [Member] | $71.53K | $71.79K | $54.10K | $64.20K | $64.40K | $85.80K | $67.88K | $44.01K | $45.91K | $37.26K | $66.46K | $90.32K | 0.2% | +11.1% |
| Public Banking Revenue [Member] | $52.64K | $48.84K | $129.51K | $289.76K | $406.25K | $405.04K | $366.67K | $288.05K | $171.83K | $294.16K | $481.15K | $523.12K | 0.2% | -87.0% |
By region
From the segment and revenue-disaggregation notes of Cryo Cell International's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.